Sponsor Pipeline

Zhongshan Hospital (Xiamen), Fudan University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07616336 Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes Myelodysplastic Syndromes Not Yet Recruiting
NCT07626021 Selinexor Monotherapy for Cytoreduction in BCR::ABL1-Negative Myeloproliferative Neoplasms Myeloproliferative Neoplasms Not Yet Recruiting
Phase 1
NCT07622862 Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM) Multiple Myeloma Refractory Not Yet Recruiting
Disease Areas
Myelodysplastic Syndromes (MDS) (1) Multiple Myeloma (1) Myelofibrosis (1)
Get alerts when Zhongshan Hospital (Xiamen), Fudan University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free